AG真人·(中国)官方网站

Apeloa has various R&D facilities in the cities of Hengdian, Hangzhou, Shanghai and Chengdu, mainly focused in the innovation of chemical synthesis, biotechnology and pharmaceutical engineering. The research institute has been equipped with state-of-art instruments such as NMR, LC-MS, ICP-MS, etc. Currently, there are over 400 scientists in the institute including a group of the high level research professionals with western education background and working experience in multi-national pharmaceutical companies. We are committed and endeavor to the development of novel therapeutic medicines, specifically in the field of cardiovascular, infectious disease and oncology, to improve people’s living quality.

API Technology Center, Engineering Technology Center, CDMO R&D Center and Yosemade Medicine Research Institute carry out scientific research activities for the three business divisions at Apeloa individually and they are the major driving force for Apeloa to reach its business achievement.

Apeloa has built strong external collaboration with academies, biotech, and other research institutions. The Academician Station and Post-doctoral Station in Apeloa attract the top talents throughout the world and makes Apeloa as an outstanding platform for innovation